BD 2142075 - PowerLoc MAX PAK Safety Infusion Set, 20G x 0.75", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

BD 2142075 - PowerLoc MAX PAK Safety Infusion Set, 20G x 0.75", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

The BD 2142075 PowerLoc MAX PAK Safety Infusion Set is a sterile, single-use port-access solution designed for accessing compatible subcutaneously implanted vascular ports. The set features a 20-gauge non-coring Huber needle with a 0.75-inch length and is configured without a Y-injection site.

The PowerLoc MAX system provides a closed fluid pathway for administering compatible fluids and medications, withdrawing blood specimens, flushing implanted ports, and delivering contrast media through appropriately rated power-injectable ports. The 20-gauge configuration supports a broad range of infusion and diagnostic imaging applications, while the 0.75-inch needle length is commonly selected for implanted ports positioned relatively close to the skin surface.

An integrated safety mechanism is housed within the plastic needle base. After therapy is completed and the needle is withdrawn through the base, the mechanism covers the needle bevel and locks it into the protective housing. This single-step activation is designed to help reduce accidental needlestick exposure during needle removal, transportation, and disposal.

The low-profile, wingless base supports dressing application and access-site management. A padded, non-absorbent footprint is designed to support patient comfort, while the rotating needle hub allows the tubing to be positioned according to the clinical environment and dressing configuration.

The MAX PAK format provides an organized, all-in-one solution intended to simplify the multi-step sterile port-access preparation process. BD 2142075 is supplied five sets per case.

Key Benefits

• 20-gauge non-coring Huber needle supports access to compatible implanted vascular ports.
• 0.75-inch needle length is suitable for appropriately positioned ports with limited tissue depth over the septum.
• Power-injectable design supports compatible contrast-enhanced imaging procedures.
• Integrated safety mechanism covers and locks the needle bevel following removal.
• Single-step safety activation helps reduce accidental needlestick exposure.
• Low-profile design supports secure dressing placement and routine access-site care.
• Wingless base helps reduce bulk beneath the dressing.
• Non-absorbent padded footprint is designed to support patient comfort during access.
• Rotating needle hub supports convenient tubing positioning and site management.
• Stable base helps maintain the position of the access needle during therapy.
• Compatible with appropriate single-lumen and dual-lumen implanted ports.
• Configuration without a Y-injection site provides a direct fluid pathway.
• Maximum power-injection flow rate of up to 5 mL per second for compatible 20-gauge configurations when all system requirements are met.
• MAX PAK presentation helps simplify sterile preparation and procedural organization.
• Five-per-case packaging supports controlled inventory management.

Compatibility and Applications

The BD 2142075 PowerLoc MAX PAK Safety Infusion Set is intended for use with compatible surgically implanted subcutaneous vascular access ports that accept non-coring Huber needles.

When used for power injection, the implanted port, needle set, connectors, extension components, and every other part of the fluid pathway must be specifically rated for power injection. The operating pressure and flow rate must not exceed the lowest-rated component within the complete system.

Potential applications include intravenous medication administration, chemotherapy, hydration therapy, antibiotic therapy, parenteral nutrition, blood product administration, port flushing, blood specimen collection, and contrast-media injection during compatible diagnostic imaging procedures.

The 20-gauge needle provides a balance between flow capability and needle diameter. It may be selected for routine infusion therapy, blood withdrawal, and compatible power-injection applications when a 20-gauge device meets the clinical and manufacturer requirements.

The 0.75-inch length is generally appropriate when the implanted port septum can be reached securely with a shorter access needle. Clinicians must assess the depth of the port beneath the skin before selecting the needle length. A needle that is too short may not fully access the port septum, while an unnecessarily long needle may affect stability, securement, and dressing placement.

The set is supplied without a Y-injection site. This configuration is suitable for workflows that use a direct tubing pathway and do not require an additional secondary injection or medication-access point.

Compatibility should be confirmed with the implanted port model, port depth, septum design, prescribed therapy, infusion pump, power injector, connector system, dressing materials, and institutional vascular-access protocol.

Usage Guidelines

The BD 2142075 should be used only by healthcare professionals who are trained and authorized to access implanted vascular ports. Current manufacturer instructions, aseptic technique, facility policy, and the implanted port manufacturer's instructions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, implanted port type, and power-injection status.
• Assess the location and depth of the implanted port before selecting the 0.75-inch needle.
• Verify that the 20-gauge size is appropriate for the prescribed infusion, blood withdrawal, or imaging procedure.
• Inspect the sterile package for damage, moisture, punctures, contamination, or compromised integrity.
• Prepare the access site using the skin antisepsis procedure required by institutional policy.
• Prime the infusion set completely with an approved solution using aseptic technique.
• Ensure that air has been removed from the tubing before connection to the implanted port.
• Stabilize the port and insert the non-coring needle perpendicular to the septum using an approved technique.
• Advance the needle until appropriate contact with the base of the port reservoir is achieved.
• Verify correct placement by aspirating for blood return when required by the facility protocol.
• Flush the port according to the implanted port manufacturer's instructions.
• Position the rotating hub and tubing to minimize pressure, pulling, and dressing disruption.
• Apply an appropriate sterile dressing and secure the access device according to institutional policy.
• Monitor the site for pain, swelling, redness, leakage, displacement, or other signs of complications.
• Confirm power-injection eligibility before connecting the set to a power injector.
• Do not exceed the permitted pressure or flow rate for any component within the system.
• After therapy, flush and lock the implanted port according to the prescribed protocol.
• Withdraw the needle while stabilizing the port and activate the integrated safety mechanism.
• Confirm that the needle bevel is fully covered and locked within the protective base.
• Dispose of the used set immediately in an approved sharps container.

Stop the procedure and assess the device if resistance occurs during flushing, expected blood return cannot be obtained, the patient reports unusual discomfort, or swelling, leakage, or other abnormalities develop at the access site.

Certifications and Safety Standards

The BD PowerLoc MAX system is classified as a non-coring Huber needle and infusion set intended for insertion into the septum of a surgically implanted vascular port. It provides a fluid pathway for administering compatible fluids and medications and for obtaining blood specimens through implanted vascular access devices.

When used with an implanted port indicated for power injection, the PowerLoc MAX set may also be used for power injection of contrast media within the pressure and flow limits specified by the manufacturer.

The device is supplied sterile and is intended for single use. Appropriate aseptic technique and protection of the sterile package are required to preserve device integrity before use.

The integrated safety mechanism supports occupational exposure-control procedures by covering and locking the needle bevel following removal. This feature does not replace proper sharps handling, personal protective equipment, clinician training, or immediate disposal in an approved sharps container.

The corresponding PowerLoc MAX 20G x 0.75-inch configuration is specified as latex-free and DEHP-free and is sterilized using ethylene oxide. Healthcare organizations should verify these specifications against the current packaging and manufacturer documentation supplied with SKU 2142075.

Facilities should also confirm current FDA clearance, UDI information, shelf life, maximum pressure, flow-rate limitations, material composition, and other regulatory requirements before clinical implementation.

Comparison with Competitors

Compared with conventional non-safety port-access needles, the BD PowerLoc MAX includes a built-in mechanism that covers and locks the needle bevel during deaccessing. This can help reduce accidental needlestick exposure between removal and final disposal.

Compared with winged Huber needle sets, the wingless PowerLoc MAX base provides a low-profile footprint that may simplify dressing placement and improve access-site visibility. Winged designs may still be preferred when clinicians require wings for insertion control or stabilization.

Compared with non-power-injectable infusion sets, the PowerLoc MAX is designed for power injection when used with a compatible power-injectable implanted port. Standard non-power-rated Huber needles must not be substituted for high-pressure contrast-media procedures.

Compared with sets containing a Y-injection site, BD 2142075 provides a direct tubing pathway without an additional secondary access point. This may reduce unnecessary connections in workflows where secondary medication delivery is not required.

Compared with longer 1-inch or 1.5-inch access needles, the 0.75-inch configuration may provide a more appropriate profile for superficial implanted ports. Correct length selection can support secure septum access while reducing unnecessary needle height above the skin.

Compared with 19-gauge configurations, the 20-gauge needle has a smaller external diameter while retaining power-injection capability up to the specified limit. Compared with 22-gauge sets, it generally supports a higher maximum power-injection flow rate when used within manufacturer requirements.

Alternative safety infusion sets may differ in gauge, needle length, safety activation method, base design, tubing configuration, power-injection rating, Y-site availability, included preparation components, and package quantity. BD 2142075 combines a 20-gauge, 0.75-inch non-coring needle with a low-profile padded base, integrated safety mechanism, and MAX PAK presentation.

Typical User Profile and Application Scenarios

The BD 2142075 PowerLoc MAX PAK Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing implanted vascular ports. Typical users include infusion nurses, oncology nurses, radiology nurses, vascular-access specialists, physicians, advanced practice clinicians, and other qualified clinical personnel.

Common use environments include hospitals, oncology centers, outpatient infusion clinics, diagnostic imaging departments, ambulatory treatment centers, emergency departments, specialty practices, and other facilities where implanted vascular ports are accessed.

The product may be selected for patients whose implanted port can be accessed appropriately with a 0.75-inch needle and whose prescribed treatment or diagnostic procedure is compatible with a 20-gauge access device.

Typical application scenarios include chemotherapy administration, antibiotic infusion, hydration therapy, parenteral nutrition, blood specimen collection, routine port maintenance, and power injection of contrast media during compatible imaging procedures.

The configuration without a Y-injection site is particularly useful when a direct connection is preferred and the treatment plan does not require secondary access through the infusion tubing.

Best Practices for Use and Maintenance

The BD 2142075 is a sterile, single-use device and does not require maintenance as reusable equipment. Best practices focus on proper storage, product selection, aseptic preparation, port-access technique, site monitoring, safety activation, and disposal.

• Store unopened products under the environmental conditions stated by the manufacturer.
• Protect packages from moisture, excessive heat, freezing, crushing, punctures, and contamination.
• Rotate inventory according to expiration dates and facility stock-control procedures.
• Verify the BD 2142075 catalog number before opening the package.
• Confirm the 20-gauge size, 0.75-inch length, and absence of a Y-injection site.
• Assess port depth before selecting the needle length.
• Use strict aseptic technique during preparation, priming, insertion, connection, and dressing application.
• Prime the tubing completely before connecting it to the implanted port.
• Stabilize the port during insertion and removal.
• Use the rotating hub to position the tubing without twisting or applying pressure to the access site.
• Monitor the site throughout therapy for signs of infiltration, extravasation, infection, or displacement.
• Confirm the power-injectable status of the complete access system before a powered procedure.
• Never exceed the lowest pressure or flow-rate limit of any connected component.
• Do not bend, cut, repair, modify, or otherwise alter the device.
• Do not reuse, wash, resterilize, or reprocess the single-use set.
• Verify complete safety activation after needle withdrawal.
• Place the protected device directly into an approved sharps container.

Regulatory and Safety Information

The BD 2142075 PowerLoc MAX PAK Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, implanted port instructions, clinical judgment, and institutional policy.

Before use, verify the product identity, 20-gauge size, 0.75-inch needle length, sterile package integrity, expiration date, and compatibility with the implanted port. Do not use a product that is expired, damaged, contaminated, or supplied in compromised packaging.

The set should not be used for power injection unless the implanted port and every connected component are specifically rated for power injection. The permitted pressure, flow rate, contrast-media viscosity, and other operating conditions must be verified before the procedure.

The maximum recommended power-injection rate for compatible 20-gauge PowerLoc MAX configurations is up to 5 mL per second when used under the conditions specified by the manufacturer. The lowest-rated component within the entire system determines the maximum allowable operating limit.

Incorrect needle-length selection, incomplete septum access, excessive pressure, needle displacement, or improper securement may cause infiltration, extravasation, tissue injury, leakage, port damage, interrupted treatment, or other complications.

Because this model does not include a Y-injection site, it does not provide a secondary medication-access point within the tubing. Clinical teams should confirm that the direct configuration is appropriate for the intended procedure before opening the package.

The safety mechanism should be activated according to current manufacturer instructions. The used device remains a contaminated sharp even after the needle bevel is covered and must be discarded immediately in an approved sharps container.

The product is supplied as five sets per case. Distributor listings may identify it as temperature sensitive, non-returnable, restricted to continental United States distribution, or subject to special-order requirements. Purchasing personnel should confirm current availability, shipping eligibility, storage requirements, and return conditions before ordering.

How to Order

Select the BD 2142075 - PowerLoc MAX PAK Safety Infusion Set without Y-Injection Site, 20G x 0.75" and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.